期刊文献+

氟哌啶醇癸酸酯治疗难治性精神分裂症34例临床分析 被引量:1

Haloperidol Deeanoate for the Treatment Refractory Schizophrenia: A Clinical Study of 34 Cases
下载PDF
导出
摘要 目的:了解氟哌啶醇癸酸酯治疗难治性精神分裂症疗效。方法:34例均符合DSM-Ⅲ-R中难治性精神分裂症停用其它抗精神病药物后1周,给予氟哌啶醇癸酸酯50~150mg/月,疗程16周至48周,治疗前后测定BPRS量表一次。结果:氟哌啶醇癸酸酯治疗难治性精神分裂症其显效率52.9%,有效率85.3%。结论:氟哌啶醇癸酸酯对难治性精神分裂症有效,副作用比较轻微。 Purpose: This study was to examine the effect of refractory schizophrenia treated with Haloperidol Deeanoate. Method: Thirty - four refractory schizophrenia patients who met the criteria of DSM - Ⅲ- R, Were discontinue other ami - schizophrenia drugs, one week, then were treated with Haloperidol Deeanoate (does: 50-150mg/month) for 16-48 weeks. Both before and after treament, these Patients Were Searched With BPRS qnestionaire. Results: Significant effective rate is 52. 9 % , and general effective rate is 85. 3 % . The most side reaction is the ex-trapyramidal syndrome (EPS).
作者 李奕
出处 《成都医药》 2000年第1期11-12,共2页
关键词 氟哌啶醇癸酸酯 精神分裂症 疗效 药物疗法 病例分析 抗精神病药 Schizophrenia Treatment Haloperidol Deeanoate
  • 相关文献

参考文献3

共引文献1

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部